Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Sun Pharma Announces the Launch of ILUMYA for Treatment of Plaque Psoriasis in Japan

Sun Pharmaceutical Industries Limited and includesits subsidiaries and/or associate companies) announced that its wholly-owned Japanese subsidiary has launched ILUMYA® Subcutaneous Injection 100 mg Syringe (Nonproprietary name: tildrakizumab(genetical recombination), “ILUMYA”) in Japan for the treatment of Plaque Psoriasis in adult patients who have an inadequate response to conventional therapies. ILUMYA is a humanized lgG1/k monoclonal antibody […]

The post Sun Pharma Announces the Launch of ILUMYA for Treatment of Plaque Psoriasis in Japan first appeared on World Pharma Today.



This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here

Share the post

Sun Pharma Announces the Launch of ILUMYA for Treatment of Plaque Psoriasis in Japan

×

Subscribe to Leading Pharmaceutical Industry Online Platform

Get updates delivered right to your inbox!

Thank you for your subscription

×